Documents

June 2011

• GPhA Comments On Biosimilars Fees
• BIO's Comments On FDA's Biosimilars Fee Proposal
• IRS Seeks Comments On Use Of Fees To Pay For CER
• 41 Democratic Senators Stand Firm Against Medicaid Cuts
• FDA Draft Guidance Narrows Definition Of Nanotechnology
• Hatch: When Physicians Profit From Device Sales, They Perform More Surgeries Involving Those Devices
• Bipartisan Group Of Senators Requests Investigation Of Physician-Owned Distributors
• AMGA Letter To OMB On ACO Rule
• E&C Leaders Request FDA Briefing On E. Coli Outbreak
• AHIP Commissioned Study Finds High Hospital Concentration in 80 Percent of Markets
• OSHA Publishes Final Rule On SIP
• MOU Calls For U.S., Canadian Work Health Groups To Work Together
• Woodcock Email Detailing CDER Compliance Office Reorganization
• New AHRQ Brief Outlines Patient-Centered Medical Home Strategies
• Solis Names Eight New Members To Construction Advisory Panel
• CFSAN Giving Grants To Local Govs For Food Safety Compliance
• Another Survey Finds Half of All Employers Could Drop Coverage
• AHRQ Awards 5-Year $10 Million Grant To study Use Of IT To Improve Older Adults' Health Care
• AdvaMed Targets FDA Device Review Reforms In Competitiveness Agenda
• House Dems Call On GOP To Hold Hearing On Threat Of E. Coli Outbreak
• NACOSH To Meet June 21-22
• Brown Asks CMS To Investigate Implications Of Price Hike For Gout Drug
• AIHA Signs Deal With Canadian Group To Advance Safety And Health
• CMS, HRSA Announce FQHC Primary Care Practice Demo
• DOJ Court Brief Defending IPAB